Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Towa Pharmaceutical Net Income (Quarterly) : 34.71M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.71M |
| March 31, 2026 | -75.41M |
| December 31, 2025 | 57.56M |
| September 30, 2025 | 38.67M |
| June 30, 2025 | 17.38M |
| March 31, 2025 | 28.62M |
| December 31, 2024 | 52.95M |
| September 30, 2024 | 7.103M |
| June 30, 2024 | 35.26M |
| March 31, 2024 | 31.35M |
| December 31, 2023 | 30.87M |
| September 30, 2023 | 15.24M |
| June 30, 2023 | 34.54M |
| March 31, 2023 | 1.639M |
| December 31, 2022 | -5.006M |
| September 30, 2022 | 9.376M |
| June 30, 2022 | 10.59M |
| March 31, 2022 | 7.858M |
| December 31, 2021 | 50.63M |
| September 30, 2021 | 35.71M |
| June 30, 2021 | 48.55M |
| March 31, 2021 | 42.52M |
| December 31, 2020 | 30.59M |
| September 30, 2020 | 28.68M |
| June 30, 2020 | 31.03M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.43M |
| December 31, 2019 | 35.90M |
| September 30, 2019 | 30.76M |
| June 30, 2019 | 34.24M |
| March 31, 2019 | 27.42M |
| December 31, 2018 | 37.93M |
| September 30, 2018 | 23.42M |
| June 30, 2018 | 32.67M |
| March 31, 2018 | -8.107M |
| December 31, 2017 | 27.19M |
| September 30, 2017 | 20.71M |
| June 30, 2017 | 18.04M |
| March 31, 2017 | 6.798M |
| December 31, 2016 | 43.09M |
| September 30, 2016 | 11.57M |
| June 30, 2016 | -10.18M |
| March 31, 2016 | 11.95M |
| December 31, 2015 | 18.89M |
| September 30, 2015 | 14.52M |
| June 30, 2015 | 18.45M |
| March 31, 2015 | 18.57M |
| December 31, 2014 | 42.27M |
| September 30, 2014 | 26.80M |
| June 30, 2014 | 12.56M |
| March 31, 2014 | 8.301M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Eisai Co., Ltd. | 120.18M |
| Chugai Pharmaceutical Co., Ltd. | 730.02M |
| Santen Pharmaceutical Co., Ltd. | 45.18M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 447.93M |
| Total Expenses (Quarterly) | 413.23M |
| EPS Diluted (Quarterly) | 0.7051 |
| Enterprise Value | 2.434B |
| Gross Profit Margin (Quarterly) | 36.56% |
| Profit Margin (Quarterly) | 7.75% |
| Earnings Yield | 4.34% |
| Operating Earnings Yield | 12.37% |
| Normalized Earnings Yield | 6.614 |